Concert An Alheimer's Disease Investigational Trial
Patients and Caregivers
About the study
Entry requirements
Site locations
Clinical studies
Alzheimer's disease
Physcians
About dimebon
About the study
Join the Concert Study
1
Check if there is a study site in your area.
2
Check the study requirements.
Call toll-free
in the United States
in the United Kingdom
in Australia
in New Zealand.
What should you expect during the Concert Study?
Patients will be asked to stay in the Concert Study for 12 months. Patients will take tablets 3 times daily in addition to the Aricept® (donepezil HCl tablets) they are already taking. Two-thirds of patients will receive Dimebon, the drug being studied. One-third of patients will receive placebo (sugar pill), which does not contain active medicine.
Patients and their main caregiver will be seen at their study doctor's office about 10 times. At each visit, the doctor will assess the patient's safety and how well the treatment is working, as well as interview the caregiver. Patients will receive medical care throughout the duration of the study.
Continuing treatment on Dimebon
All patients who complete the 52-week study, including those taking placebo, will be able to take part in another study where they will receive Dimebon at no financial cost.
The Concert Study is a Phase 3 trial sponsored by
Medivation, Inc, and Pfizer Inc.
Home  |  Terms of use  |  Privacy policy
Aricept® is a registered trademark of Eisai Co, Ltd.
© 2009 Medivation, Inc, and Pfizer Inc. All rights reserved.